IRCT201405108170N7CompletedPhase 3
The effect of Ginkgo biloba pill and inhalation aromatherapy on sexual function in postmenopausal women: A randomized controlled clinical trial
Vice Chancellor for research of Faculty of Nursing and Midwifery, Tabriz Univercity of Medical Scien0 sites180 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 180
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- Female
Inclusion Criteria
- •ability of writing in Persian language? age range of 45- 55 years; Being married and living with her husband; Lack of chronic disease; No severe emotional stress in past six months; Natural menopause
- •Exclusion criteria: No willingness to participate; occurrence of drug side effects and allergy to drugs during the study; occurrence of severe emotional stress such as death of close family; occurrence of psychological complications or severe disease during the study; Living away from husband; hysterectomy,ovarectomy , Cystocele, mastectomy, use of tobacco and alcohol, or herbal drugs, impaired sense of smell, according to one's own and other nasal problems (fractures, SD, rhinitis), gastrointestinal disturbances such as nausea, vomiting, stomach - ache, abdominal cramps, absence of any abnormal vaginal bleeding; Not currently taking drugs affecting on sexual response (anti-hypertension, Thiazide diuretics, anti-depression, anti-histamines, Barbiturates, narcotics, diazepam,amphetamines,cocaine) & no HRT
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
Effect of Ginkgo Biloba extract in comparison with placebo on prevention of tinnitus and ototoxicity in patients treated with cisplatiPrevention of ototoxicity of cisplatin.Ototoxic hearing lossIRCT2015020720982N1Tehran University of Medical Sciences48
Completed
Not Applicable
The influence of GINkGo biloba on the pharmacokinetics of the UGT substrate raltEgraviR (GINGER)HIVAIDS1004743810009841NL-OMON34438niversitair Medisch Centrum Sint Radboud18
Completed
Not Applicable
Ginkgo biloba effects in the treatment of patients with chronic schizophrenia treated with Risperidone in Joneghan Sinai HospitalSchizophrenia.F20, F29SchizophreniaIRCT138903192085N3Shahrekord University of Medical Sciences60
Completed
Not Applicable
Association of the simultaneous administration of Gingko biloba extract and absorption promoting agent with cognitive functioHealthy adultsJPRN-UMIN000043494Department of Aging Research and Geriatric Medicine IDAC, Tohoku University155
Recruiting
Phase 3
Evaluation of the Effectiveness of Ginkgo Biloba regimen on cognitive function in patients undergoing electroconvulsive therapy: Double blind clinical trialPsychosis.Other stimulant related disordersIRCT20200516047470N1Ahvaz University of Medical Sciences80